)
Cara Therapeutics (CARA) investor relations material
Cara Therapeutics SEO filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Clinical-stage biopharmaceutical company developing novel, oral small molecule therapies targeting STAT3 for fibrosis-driven diseases with significant unmet need.
Lead candidate TTI-101 is in Phase 2 for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC); TTI-109 is a second oral STAT3 inhibitor in early development.
Focus on direct STAT3 inhibition, a historically undruggable target, with differentiated mechanism and convenient oral dosing.
Pipeline includes additional indications in fibrosis and oncology, with plans for further clinical trials pending regulatory feedback.
Financial performance and metrics
As of June 30, 2025, cash and cash equivalents were $20.6M, with $20.3M in short-term investments.
Accumulated deficit reached $97.6M as of June 30, 2025.
Net loss was $5.4M for the six months ended June 30, 2025; net loss was $29.4M for the year ended December 31, 2024.
Company has not generated any revenue to date and expects continued operating losses for the foreseeable future.
Substantial doubt exists about ability to continue as a going concern without additional funding.
Use of proceeds and capital allocation
IPO is a resale registration for 2,084,117 shares by selling stockholders; company will not receive proceeds from these sales.
Proceeds from prior financings and the merger are allocated to ongoing R&D, clinical trials, and general operations.
Additional funding will be sought through equity, debt, or strategic partnerships to support operations and clinical development.
Next Cara Therapeutics earnings date
Next Cara Therapeutics earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)